LONGITUDINAL ANALYSIS OF REAL-WORLD BASAL INSULIN UTILIZATION FOR TYPE I AND TYPE II DIABETES PATIENTS SWITCHING TO INSULIN GLARGINE U-300 (TOUJEO®)

被引：0
|
作者：
Zhang, Yvonne [1 ]
Sauriol, Luc [2 ]
Glass, Jennifer [1 ]
Millson, Brad [1 ]
机构：
[1] QuintilesIMS, Mississauga, ON, Canada
[2] Sanofi, Montreal, PQ, Canada
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S242 / S242
页数：1
相关论文
共 50 条
  • [1] The role of Toujeo®, insulin glargine U-300, in the treatment of diabetes mellitus
    Brown, Meagan A.
    Davis, Courtney S.
    Fleming, Laurie W.
    Fleming, Joshua W.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2016, 28 (09) : 503 - 509
  • [2] Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland
    Peter Wiesli
    Marcus Schories
    Diabetes Therapy, 2018, 9 : 2325 - 2334
  • [3] Improved Glycemic Control with Insulin Glargine 300U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland
    Wiesli, Peter
    Schories, Marcus
    DIABETES THERAPY, 2018, 9 (06) : 2325 - 2334
  • [4] Improved real-world outcomes for type 2 diabetes patients on basal-bolus insulin therapy switching to insulin glargine 300 U/ml vs. insulin glargine 100 U/ml and insulin Detemir
    Wu, Jasmanda
    Bailey, Timothy S.
    Bosnyak, Zsolt
    Westerbacka, Jukka
    Gupta, Rishab A.
    Menon, Arjun A.
    Nicholls, Charlie
    Blonde, Lawrence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 416 - 417
  • [5] Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real-world patients with type 1 and type 2 diabetes
    Oya, Junko
    Nakagami, Tomoko
    Hasegawa, Yukiko
    Katamine, Aki
    Kondo, Yuichiro
    Babazono, Tetsuya
    JOURNAL OF DIABETES INVESTIGATION, 2021, 12 (11) : 1983 - 1991
  • [6] The effectiveness of insulin glargine 300 U/mL among type 2 diabetes patients: Analysis of a real-world data in Israel
    Cohen, Cheli Melzer
    Banon, Tamar
    Shalev, Varda
    Chodick, Gabriel
    ENDOCRINOLOGY DIABETES & METABOLISM, 2020, 3 (03)
  • [7] Switching to insulin glargine 300 units/mL in real-world older patients with type 2 diabetes (DELIVER 3)
    Bailey, Timothy S.
    Wu, Jasmanda
    Zhou, Fang L.
    Gupta, Rishab A.
    Menon, Arjun A.
    Berhanu, Paulos
    Westerbacka, Jukka
    Van Vleet, John
    Blonde, Lawrence
    DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2384 - 2393
  • [8] Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
    Ragonese, Mauro
    Larosa, Monica
    Angotti, Stefania
    Annese, Stefania
    Cruciani, Laura
    Dainelli, Michela
    Lucisano, Giuseppe
    Prosperini, Giuseppe
    Sacco, Michele
    Salomone, Enrica
    Saponara, Caterina
    Semprini, Roberta
    Rossi, Maria Chiara
    Nicolucci, Antonio
    DIABETES THERAPY, 2020, 11 (10) : 2283 - 2298
  • [9] Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
    Mauro Ragonese
    Monica Larosa
    Stefania Angotti
    Stefania Annese
    Laura Cruciani
    Michela Dainelli
    Giuseppe Lucisano
    Giuseppe Prosperini
    Michele Sacco
    Enrica Salomone
    Caterina Saponara
    Roberta Semprini
    Maria Chiara Rossi
    Antonio Nicolucci
    Diabetes Therapy, 2020, 11 : 2283 - 2298
  • [10] Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
    Lau, Ip Tim
    Lee, Ka Fai
    So, Wing Yee
    Tan, Kathryn
    Yeung, Vincent Tok Fai
    DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 273 - 284
12345